[Clinical study of an aromatic retinoid (Ro 10-9359) for the treatment of oral hyperkeratosis].
The effects of the vitamin A-derived aromatic retinoid (Ro 10-9359) on 25 patients with oral hyperkeratosis were good. Compared with vitamin A, toxicity is reduced and the recurrence quota after discontinuation of the preparation is lower.
D002214:Capsules; D002986:Clinical Trials as Topic; D005050:Etretinate / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007972:Leukoplakia, Oral / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009061:Mouth Mucosa / Q000187:drug effects; D013997:Time Factors; D014212:Tretinoin / Q000031:analogs & derivatives*
D002214:Capsules; D014212:Tretinoin; D005050:Etretinate
Klinische Untersuchung eines aromatischen Retinoids (Ro 10-9359) zur Behandlung oraler Hyperkeratosen.